As a metabolic disorder, obesity can cause secondary kidney damage, which is called obesity-related glomerulopathy (ORG). As the incidence of obesity increases worldwide, so does the incidence of end-stage renal disease (ESRD) caused by ORGs. However, there is still a lack of effective strategies to prevent and delay the occurrence and development of ORG. Therefore, a deeper understanding and elaboration of the pathogenesis of ORG is conducive to the development of therapeutic drugs for ORG. Here, we review the characteristics of pathological lesions of ORG and describe the roles of lipid metabolism disorders and mitochondrial oxidative stress in the development of ORG. Finally, we summarize the current available drugs or compounds for the treatment of ORG and suggested that ameliorating renal lipid metabolism and mitochondrial function may be potential therapeutic targets for ORG.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535317 | PMC |
| http://dx.doi.org/10.3390/ph16091256 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Kidney consequences of obesity.
Pediatr Nephrol
December 2024
Division of Nephrology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Herein, we review the devastating consequences of the worldwide obesity epidemic on kidney health and outcomes. We submit that the obesity epidemic is the most pressing public health crisis facing the nephrology community today. A historical approach has been undertaken, wherein major breakthroughs in the recognition and understanding of obesity-related kidney disease (ORKD) are highlighted.
View Article and Find Full Text PDFC3G improves lipid droplet accumulation in the proximal tubules of high-fat diet-induced ORG mice.
Pharmacol Res
January 2025
Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China. Electronic address:
Obesity-related glomerulopathy (ORG) represents an escalating public health with no effective treatments currently available. Abnormal lipid metabolism and lipid droplet deposition in the kidneys are key contributors to ORG. Cyanidin-3-glucoside (C3G) has shown potential in regulating lipid metabolism and may offer reno-protective effects; however, its therapeutic efficacy and underlying mechanisms in ORG remain unclear.
View Article and Find Full Text PDFDefinition of hyperfiltration taking into account age-related decline in renal function in kidney donor candidates with obesity and glucose tolerance disorder.
Hypertens Res
December 2024
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
The definition of hyperfiltration, the main pathogenesis in renal impairment in obesity and diabetes mellitus, is uncertain. Glomerular filtration rate (GFR) declines physiologically with aging, and there is inaccuracy in GFR in obesity due to body surface area (BSA) correction. Here, we defined hyperfiltration using GFR without BSA correction, but with inclusion of aging, and investigated hyperfiltration using this definition and absolute GFR > 125 mL/min.
View Article and Find Full Text PDFObesity-Related Kidney Disease in Bariatric Surgery Candidates.
Obes Surg
January 2025
Department of Nephrology, Unidade Local de Saúde de Santo António, (ULS Santo António), Porto, Portugal.
Article Synopsis
- Obesity adversely affects kidney health, but the specific kidney dysfunction markers in bariatric surgery candidates are not well understood, prompting a study comparing these biomarkers to those of living kidney donors.
- The study involved matching 200 bariatric candidates with 200 living kidney donors based on sex and age, using a 24-hour urine collection to assess protein levels and kidney function.
- Findings indicated that patients with obesity had higher creatinine clearance and proteinuria than kidney donors, underscoring the need to reconsider how kidney function is evaluated in obese individuals considering bariatric surgery, particularly regarding body surface area adjustments.
Butyrate attenuates high-fat diet-induced glomerulopathy through GPR43-Sirt3 pathway.
Br J Nutr
November 2024
Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
The incidence of obesity-related glomerulopathy (ORG) is rising worldwide with very limited treatment methods. Paralleled with the gut–kidney axis theory, the beneficial effects of butyrate, one of the short-chain fatty acids (SCFA) produced by gut microbiota, on metabolism and certain kidney diseases have gained growing attention. However, the effects of butyrate on ORG and its underlying mechanism are largely unexplored.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!